Key terms
About AZN
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest AZN news
Apr 19
6:21pm ET
VGK vs. EZU: Which Is the Better European Stock ETF?
Apr 18
9:41am ET
Unusually active option classes on open April 18th
Apr 16
12:49pm ET
AstraZeneca upgraded to Hold from Sell at Deutsche Bank (earlier)
Apr 16
7:12am ET
AstraZeneca: Imfinzi + chemo doubled OS at three years for patients with BTC
Apr 16
6:20am ET
AstraZeneca reports updated exploratory results from TOPAZ-1 Phase 3 trial
Apr 11
2:27pm ET
AstraZeneca’s AGM: Resolutions Passed with Support
Apr 11
7:05am ET
AstraZeneca announces FDA approval for Fasenra
Apr 11
6:14am ET
AstraZeneca increases 2024 dividend by 7% to $3.10 per share
Apr 09
9:00pm ET
ZTS, EXAS, AZN: Which Biotech Stock Is the Better Buy?
Apr 08
8:41am ET
Nuvectis says NXP900 demonstrates robust activity in NSCLC
Apr 08
6:58am ET
AstraZeneca’s Enhertu Wins US Approval for Tumours
Apr 07
6:04am ET
ENHERTU approved for treatment of unresectable or metastatic HER2 positive
Apr 05
7:03am ET
AstraZeneca releases ADRIATIC Phase III trial results on IMFINZI
Apr 05
6:57am ET
AstraZeneca’s Imfinzi Shows Promise in Lung Cancer Trial
Apr 05
5:56am ET
AstraZeneca: Imfinzi significantly improved OS and PFS in LS-SCLS in trial
Apr 04
12:06pm ET
AstraZeneca call volume above normal and directionally bullish
Apr 04
4:32am ET
AstraZeneca placed on ‘Positive Catalyst Watch’ at JPMorgan
Apr 02
1:58pm ET
AstraZeneca Reports Voting Rights and Share Capital
Apr 02
9:28am ET
AstraZeneca’s Voydeya Wins FDA Approval
Apr 02
8:28am ET
AstraZeneca’s Cancer Drug Closer to FDA Approval
Apr 02
7:04am ET
AstraZeneca, Daiichi Sankyo datopotamab deruxtecan BLA accepted in the U.S.
Apr 01
7:10am ET
AstraZeneca announces FDA approval of Voydeya
Apr 01
6:10am ET
AstraZeneca shareholders urged to oppose EUR 18.7M pay plan for CEO, FT says
Mar 28
2:49pm ET
What Fusion Pharmaceuticals (NASDAQ:FUSN) Acquisition Means for Investors
Mar 27
6:25am ET
AstraZeneca, Sanofi announce Beyfortus approved in Japan
Mar 27
6:24am ET
AstraZeneca’s Truqap with Faslodex approved by Japanese MHLW
Mar 26
5:07am ET
QQQ ETF Update, 3/26/2024
Mar 25
7:57am ET
AstraZeneca’s Ultomiris Revolutionizes NMOSD Treatment
Mar 25
7:10am ET
FDA approves AstraZeneca’s Ultomiris for rare nerve disease NMOSD
Mar 25
6:17am ET
AstraZeneca reports Ultomiris approved in U.S. for adults with NMOSD
Mar 22
5:58am ET
QQQ ETF Update, 3/22/2024
No recent press releases are available for AZN
AZN Financials
Key terms
Ad Feedback
AZN Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
AZN Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range